ZIMMER BIOMET HOLDINGS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $634.1m $524.4m $542.8m $617.9m $802.1m $478.5m $375.7m $415.8m $525.5m $591.9m
Prepaid Expense and Other Assets, Current $465.7m $414.5m $352.3m $357.1m $377.8m $277.6m $324.5m $366.1m $430.1m $537.3m
Inventory, Net $2.0b $2.1b $2.3b $2.4b $2.5b $2.4b $2.1b $2.4b $2.2b $2.3b
Assets, Current $4.7b $4.5b $4.4b $4.7b $5.1b $4.9b $4.4b $4.6b $4.7b $5.1b
Property, Plant and Equipment, Net $2.0b $2.0b $2.0b $2.1b $2.0b $2.0b $1.9b $2.1b $2.0b $2.2b
Goodwill $10.6b $10.7b $9.6b $9.6b $9.3b $9.2b $8.6b $8.8b $9.0b $9.9b
Intangible Assets, Net (Excluding Goodwill) $8.8b $8.4b $7.7b $7.3b $7.1b $6.3b $5.1b $4.9b $4.6b $4.7b
Operating Lease, Right-of-Use Asset $266.7m $274.5m $271.2m $196.4m $203.8m $213.5m $204.2m
Other Assets, Noncurrent $553.6m $388.8m $405.0m $980.1m $969.4m $1.1b $1.1b $1.2b $1.1b $1.1b
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $1.6b $1.5b $1.3b $1.4b $1.5b $1.4b $1.4b $1.4b $1.5b $1.7b
Accrued Liabilities, Current $789.1m $795.2m $670.6m $778.1m $890.0m $735.3m $582.3m $627.7m $734.1m $834.5m
Assets $26.7b $26.0b $24.1b $24.6b $24.4b $23.5b $21.1b $21.5b $21.4b $23.1b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $64.2m $75.0m $69.3m $53.0m $52.9m $53.2m $57.5m
Accounts Payable, Current $364.5m $330.2m $362.6m $400.9m $330.0m $351.2m $354.1m $410.6m $194.6m $303.0m
Operating Lease, Liability, Noncurrent $215.5m $217.8m $220.2m $167.3m $174.4m $190.2m $175.5m
Long-term Debt, Current Maturities $575.6m $1.2b $525.0m $1.5b $500.0m $1.6b $544.3m $900.0m $863.0m $587.1m
Long-term Debt, Excluding Current Maturities $10.7b $8.9b $8.4b $6.7b $7.6b $5.5b $5.2b $4.9b $5.3b $6.9b
Liabilities, Current $2.4b $3.0b $2.4b $3.4b $2.6b $3.5b $2.4b $2.9b $2.5b $2.6b
Deferred Income Tax Liabilities, Net $790.4m $665.6m $474.8m $357.6m $352.5m $244.1m
Other Liabilities, Noncurrent $936.3m $445.8m $350.0m $557.8m $656.4m $609.6m $632.6m $652.1m $744.1m $626.1m
Deferred Tax Liabilities, Net $2.8b $853.3m $898.6m $368.7m $338.6m $236.2m $67.4m $32.4m
Liabilities $17.0b $14.2b $12.9b $12.2b $12.2b $10.8b $9.0b $9.0b $8.9b $10.4b
Stockholders’ equity:
Common Stock, Value, Issued $3.1m $3.1m $3.1m $3.1m $3.1m $3.1m $3.1m $3.2m $3.2m $3.2m
Retained Earnings (Accumulated Deficit) $8.5b $10.0b $9.5b $10.4b $10.1b $10.3b $9.6b $10.4b $11.1b $11.6b
Accumulated Other Comprehensive Income (Loss), Net of Tax ($434.0m) ($83.2m) ($187.4m) ($241.9m) ($297.8m) ($231.6m) ($179.3m) ($191.0m) ($262.8m) ($205.7m)
Additional Paid in Capital, Common Stock $8.4b $8.5b $8.7b $8.9b $9.1b $9.3b $9.5b $9.8b $10.0b $10.2b
Stockholders' Equity Attributable to Parent $9.7b $11.7b $11.3b $12.4b $12.2b $12.7b $12.0b $12.5b $12.5b $12.7b
Stockholders' Equity Attributable to Noncontrolling Interest $1.0m ($300k) $4.8m $4.7m $5.2m $5.7m $6.7m $7.7m $8.1m $8.1m
Liabilities and Equity $26.7b $26.0b $24.1b $24.6b $24.4b $23.5b $21.1b $21.5b $21.4b $23.1b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.